Regulation News

Financial regulation news from the SEC, FINRA, and government agencies. Track policy changes, enforcement actions, and compliance updates affecting markets.

IRS Warns 2026 Tax Refund Delays Likely Without Accurate Direct Deposit Details
Regulation James Calloway

IRS Warns 2026 Tax Refund Delays Likely Without Accurate Direct Deposit Details

The IRS cautions that missing or incorrect bank information will hold 2026 refunds, with updates only accepted by mail. Most e-filed refunds arrive within 21 days, but delays could extend into March.

INTU
Tax Season 2026: Key Deadlines, Refund Timelines, and Penalty Warnings
Regulation James Calloway

Tax Season 2026: Key Deadlines, Refund Timelines, and Penalty Warnings

The IRS sets April 15, 2026 as the federal filing deadline for 2025 returns, with extensions available until October. Most refunds arrive within 21 days, but some credits may delay payments until March.

XLF
GSK's RSV Vaccine Advances in Chinese Regulatory Review, Eyes 2027 Decision
Regulation James Calloway

GSK's RSV Vaccine Advances in Chinese Regulatory Review, Eyes 2027 Decision

GSK's Arexvy RSV vaccine application has been accepted for review by China's drug regulator, with a potential approval decision expected in 2027. The stock edged higher as JPMorgan raised its price target and the company's dividend ex-date approaches.

GSK PFE JPM
Meta Shares Dip Amid Regulatory Pressure in Germany and India
Regulation James Calloway

Meta Shares Dip Amid Regulatory Pressure in Germany and India

Meta Platforms stock declined roughly 1% in after-hours trading following a German court ruling ordering a €30 million payment to Deutsche Telekom and India's new three-hour content removal mandate.

META
UnitedHealth Gains Amid Medicare Rate Uncertainty and ACA Investigations
Regulation James Calloway

UnitedHealth Gains Amid Medicare Rate Uncertainty and ACA Investigations

UnitedHealth shares edged higher as investors monitored upcoming Medicare Advantage payment decisions and a House Republican probe into ACA insurers. The sector traded mixed.

UNH ELV CVS HUM CI
Hims & Hers Shares Extend Decline Amid Novo Nordisk Patent Lawsuit Over Compounded Weight-Loss Drugs
Regulation James Calloway

Hims & Hers Shares Extend Decline Amid Novo Nordisk Patent Lawsuit Over Compounded Weight-Loss Drugs

Hims & Hers Health stock fell another 5.6% as Novo Nordisk filed a patent lawsuit seeking to block compounded versions of Wegovy, tightening regulatory pressure on the online health provider's GLP-1 offerings.

NVO
JPMorgan Faces Internal Pushback Over Full-Time Office Mandate
Regulation James Calloway

JPMorgan Faces Internal Pushback Over Full-Time Office Mandate

JPMorgan Chase employees warn that resisting CEO Jamie Dimon's five-day office requirement could harm careers, as a petition for hybrid work gains limited traction.

JPM GS
Meta Faces EU Pressure Over WhatsApp AI Access, Stock Dips Slightly
Regulation James Calloway

Meta Faces EU Pressure Over WhatsApp AI Access, Stock Dips Slightly

Meta shares edged lower as EU regulators consider forcing WhatsApp to open its business platform to rival AI assistants. Separately, WhatsApp won a court ruling to challenge a €225 million privacy fine.

META
Hims & Hers Stock Extends Slide Amid Weight-Loss Pill Halt, Regulatory Pressure
Regulation James Calloway

Hims & Hers Stock Extends Slide Amid Weight-Loss Pill Halt, Regulatory Pressure

Hims & Hers Health shares fell another 4.2% premarket Tuesday, compounding a 16% drop Monday, after discontinuing its compounded semaglutide pill. The company faces a patent lawsuit from Novo Nordisk and potential FDA action.

HIMS
Crypto Kiosk Fraud Prompts Regulatory Crackdown Across U.S. States
Regulation James Calloway

Crypto Kiosk Fraud Prompts Regulatory Crackdown Across U.S. States

Americans lost over $333 million to cryptocurrency ATM scams in 2025, driving lawmakers in at least 15 states to propose stricter rules including registration mandates and enhanced warnings.

Kyndryl Shares Stabilize After Steep Plunge on Regulatory Scrutiny, Leadership Changes
Regulation James Calloway

Kyndryl Shares Stabilize After Steep Plunge on Regulatory Scrutiny, Leadership Changes

Kyndryl's stock found modest footing in premarket trading following a 55% collapse, triggered by a delayed SEC filing and an internal controls review. The IT services firm also announced the departure of its CFO and global controller.

KD IBM ACN
National Grid Shares Hold Steady Amid Regulatory Watch and Infrastructure Milestone
Regulation James Calloway

National Grid Shares Hold Steady Amid Regulatory Watch and Infrastructure Milestone

National Grid shares showed minimal movement as the company completed a key grid upgrade project. Investor focus remains on Ofgem's upcoming RIIO-3 license decision and UK interest rate volatility.

EWU